Suppr超能文献

肝内胆管癌切除术后手术及病理淋巴结评估的最佳范围

Optimal extent of surgical and pathologic lymph node evaluation for resected intrahepatic cholangiocarcinoma.

作者信息

Brauer David G, Fields Ryan C, Tan Benjamin R, Doyle M B Majella, Hammill Chet W, Hawkins William G, Colditz Graham A, Chapman William C

机构信息

Department of Surgery, Washington University School of Medicine, Alvin J. Siteman Cancer Center, St Louis, MO, USA.

Division of Oncology, Department of Medicine, Washington University School of Medicine, Alvin J. Siteman Cancer Center, St Louis, MO, USA.

出版信息

HPB (Oxford). 2018 May;20(5):470-476. doi: 10.1016/j.hpb.2017.11.010. Epub 2018 Jan 20.

Abstract

BACKGROUND

Lymph node (LN) status is an important predictor of overall survival for resected IHCC, yet guidelines for the extent of LN dissection are not evidence-based. We evaluated whether the number of LNs resected at the time of surgery is associated with overall survival for IHCC.

METHODS

Patients undergoing curative-intent (R0 or R1) resection for IHCC between 2004 and 2012 were identified within the US National Cancer Database. LN thresholds were evaluated using maximal chi-square testing and five-year overall survival was modeled using Kaplan-Meier and Cox regressions.

RESULTS

57% (n = 1,132) of 2,000 patients had one or more LNs resected and pathologically examined. In the 631 patients undergoing R0 resection with pN0 disease, maximal chi-square testing identified ≥3 LNs as the threshold most closely associated with overall survival. Only 39% of resections reached this threshold. On multivariable survival analysis, no threshold of LNs was associated with overall survival, including ≥3 LNs (p = 0.186) and the current American Joint Committee on Cancer recommendation of ≥6 LNs (p = 0.318).

CONCLUSION

In determining the extent of lymphadenectomy at the time of curative-intent resection for IHCC, surgeons should carefully consider the prognostic yield in the absence of overall survival benefit.

摘要

背景

淋巴结(LN)状态是切除的肝内胆管癌(IHCC)总体生存的重要预测指标,但淋巴结清扫范围的指南并非基于证据。我们评估了手术时切除的淋巴结数量是否与肝内胆管癌的总体生存相关。

方法

在美国国家癌症数据库中识别出2004年至2012年间接受根治性(R0或R1)切除的肝内胆管癌患者。使用最大卡方检验评估淋巴结阈值,并使用Kaplan-Meier和Cox回归对五年总体生存进行建模。

结果

2000例患者中有57%(n = 1132)切除了一个或多个淋巴结并进行了病理检查。在631例接受R0切除且病理分期为N0的患者中,最大卡方检验确定≥3个淋巴结为与总体生存最密切相关的阈值。只有39%的切除术达到该阈值。在多变量生存分析中,没有淋巴结阈值与总体生存相关,包括≥3个淋巴结(p = 0.186)和美国癌症联合委员会目前推荐的≥6个淋巴结(p = 0.318)。

结论

在确定肝内胆管癌根治性切除时的淋巴结清扫范围时,外科医生应在缺乏总体生存获益的情况下仔细考虑预后收益。

相似文献

1
Optimal extent of surgical and pathologic lymph node evaluation for resected intrahepatic cholangiocarcinoma.
HPB (Oxford). 2018 May;20(5):470-476. doi: 10.1016/j.hpb.2017.11.010. Epub 2018 Jan 20.
4
Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
World J Gastroenterol. 2015 Jan 21;21(3):935-43. doi: 10.3748/wjg.v21.i3.935.
5
Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma.
J Gastrointest Surg. 2013 Nov;17(11):1917-28. doi: 10.1007/s11605-013-2331-1. Epub 2013 Sep 19.
6
Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma.
Surg Today. 2012 Jan;42(2):147-51. doi: 10.1007/s00595-011-0057-9. Epub 2011 Nov 30.
7
Prognostic significance of lymph node ratio after resection of peri-hilar cholangiocarcinoma.
HPB (Oxford). 2011 Apr;13(4):240-5. doi: 10.1111/j.1477-2574.2010.00277.x. Epub 2011 Jan 28.

引用本文的文献

1
The State of Systematic Therapies in Clinic for Hepatobiliary Cancers.
J Hepatocell Carcinoma. 2024 Mar 27;11:629-649. doi: 10.2147/JHC.S454666. eCollection 2024.
2
Is Lymphadenectomy Reasonable for Elderly Intrahepatic Cholangiocarcinoma Patients?
J Gastrointest Surg. 2023 Nov;27(11):2451-2463. doi: 10.1007/s11605-023-05846-y. Epub 2023 Oct 2.
4
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection.
Clin Cancer Res. 2021 Jul 15;27(14):4101-4108. doi: 10.1158/1078-0432.CCR-21-0412. Epub 2021 May 7.
5
Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?
Surg Open Sci. 2020 May 16;2(3):107-112. doi: 10.1016/j.sopen.2020.04.003. eCollection 2020 Jul.
6
Resection for intrahepatic cholangiocellular cancer: new advances.
Transl Gastroenterol Hepatol. 2018 Sep 12;3:60. doi: 10.21037/tgh.2018.08.03. eCollection 2018.

本文引用的文献

4
Challenges of guarantee-time bias.
J Clin Oncol. 2013 Aug 10;31(23):2963-9. doi: 10.1200/JCO.2013.49.5283. Epub 2013 Jul 8.
5
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
J Hepatol. 2012 Apr;56(4):848-54. doi: 10.1016/j.jhep.2011.11.015. Epub 2011 Dec 13.
6
Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.
J Clin Oncol. 2011 Aug 10;29(23):3140-5. doi: 10.1200/JCO.2011.35.6519. Epub 2011 Jul 5.
8
Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
Ann Surg. 2010 Apr;251(4):675-81. doi: 10.1097/SLA.0b013e3181d3d2b2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验